🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. Berotralstat, Orladeyo 150 mg hard capsules, Berotralstat, Berotralstat, Berotralstat

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema (HAE)

    phase 3 small molecule active

    1 trial

  2. Betahistine dihydrochloride, BETASERC 24 mg, comprimé

    Lacuna Pharma Pty Ltd

    Menière's disease

    phase 3 small molecule active

    1 trial

  3. Bexicaserin, LP352 (bexicaserin) Placebo Oral Solution

    Lacuna Pharma Pty Ltd

    Dravet Syndrome

    phase 3 small molecule active

    1 trial

  4. Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Trumenba suspension for injection in pre-filled syringe Meningococcal group B vaccine (recombinant, adsorbed)

    Pari Pharma GmbH

    Asplenia

    phase 3 small molecule active

    1 trial

  5. Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 320 mg solution for injection in pre-filled pen, Bimzelx 320 mg solution for injection in pre-filled pen, Placebo matching test. 0.9% sodium chloride solution for injection (unauthorized)., Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled syringe

    Lacuna Pharma Pty Ltd

    Palmoplantar Pustulosis

    phase 3 small molecule active

    1 trial

  6. Biological Therapies Sodium Ascorbate Solution 30 g in 100 mL Injection, SODIUM CHLORIDE

    Pari Pharma GmbH

    Patient with sepsis complicated by ARDS

    phase 3 small molecule active

    1 trial

  7. Biological/Vaccine

    Vertex Pharmaceuticals (Australia) Pty.

    Type 1 Diabetes

    phase 3 mab active

    1 trial

  8. Bion 1301/FUB523

    Novartis Pharmaceuticals

    IgA nephropathy

    phase 3 small molecule active

    1 trial

  9. Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedłużonym uwalnianiu

    Lacuna Pharma Pty Ltd

    Menopause, sleep disorders in the postmenopausal period

    phase 3 small molecule active

    1 trial

  10. Blinded CDCA 250 mg TID

    Mirum Pharmaceuticals International B.V.

    CTX

    phase 3 small molecule completed

    1 trial

  11. Bortezomib STADA 2,5 mg/ml Injektionslösung, Dexamethason 0,5 mg JENAPHARM®, Empliciti 400 mg powder for concentrate for solution for infusion., Kyprolis 60 mg powder for solution for infusion, Privigen 100 mg/ml solution for infusion, Privigen 100 mg/ml solution for infusion, Imnovid 1 mg hard capsules, -, Nodexon 20 mg tabletes, Imnovid 3 mg hard capsules, Imnovid 4 mg hard capsules, Imnovid 2 mg hard capsules, Nodexon 20 mg tabletės, ELRANATAMAB, Dexamethason 4 mg JENAPHARM®

    Pfizer Australia Pty Ltd

    Relapsed/Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  12. Bosulif 500 mg film-coated tablets, Olverembatinib, Bosulif 100 mg film-coated tablets

    Lacuna Pharma Pty Ltd

    Chronic Phase Chronic Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  13. Brelovitug (BJT-778)

    Mirum Pharmaceuticals International B.V.

    Chronic Hepatitis D

    phase 3 small molecule active

    1 trial

  14. Brelovitug 300 mg

    Mirum Pharmaceuticals International B.V.

    Chronic Hepatitis D Infection

    phase 3 small molecule active

    3 trials

  15. Brexanolone

    SUPERNUS PHARMACEUTICALS, INC.

    Post Partum Depression

    phase 3 small molecule completed

    1 trial

  16. Brilaroxazine

    REVIVA PHARMACEUTICALS HOLDINGS, INC.

    Schizophrenia

    phase 3 small molecule active

    1 trial

  17. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  18. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    CMV

    phase 3 small molecule completed

    1 trial

  19. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  20. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  21. Brivaracetam

    UCB Pharma

    Epilepsy

    phase 3 small molecule completed

    1 trial

  22. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  23. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  24. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources